Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4853548
Max Phase: Preclinical
Molecular Formula: C26H32O11
Molecular Weight: 520.53
Molecule Type: Unknown
Associated Items:
ID: ALA4853548
Max Phase: Preclinical
Molecular Formula: C26H32O11
Molecular Weight: 520.53
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COC(=O)CC1=C(C)[C@H]2C[C@]3(C)C(=O)O[C@@H]4O[C@H](C)[C@]5(O)O[C@@H]([C@H]6O[C@@]16C(C)(C)O)[C@@]2(C)[C@@]51C(=O)O[C@@]413
Standard InChI: InChI=1S/C26H32O11/c1-10-12(8-14(27)32-7)23(20(3,4)30)16(35-23)15-22(6)13(10)9-21(5)17(28)34-19-25(21)24(22,18(29)37-25)26(31,36-15)11(2)33-19/h11,13,15-16,19,30-31H,8-9H2,1-7H3/t11-,13-,15+,16-,19+,21-,22+,23+,24-,25-,26+/m1/s1
Standard InChI Key: ROYAOJYHPGFWBY-RHXTZKATSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 520.53 | Molecular Weight (Monoisotopic): 520.1945 | AlogP: 0.49 | #Rotatable Bonds: 3 |
Polar Surface Area: 150.35 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.41 | CX Basic pKa: | CX LogP: 0.99 | CX LogD: 0.99 |
Aromatic Rings: 0 | Heavy Atoms: 37 | QED Weighted: 0.23 | Np Likeness Score: 1.51 |
1. Huang ZH, Liang X, Li CJ, Gu Q, Ma X, Qi SH.. (2021) Talaromynoids A-I, Highly Oxygenated Meroterpenoids from the Marine-Derived Fungus Talaromyces purpureogenus SCSIO 41517 and Their Lipid Accumulation Inhibitory Activities., 84 (10.0): [PMID:34596414] [10.1021/acs.jnatprod.1c00681] |
Source(1):